For investors
A scored pipeline of research-backed ideas
Each idea is AI-assessed against a fixed rubric — evidence, market, novelty, feasibility, wedge, simplicity — before any capital is at risk.
How every idea is scored
A fixed six-dimension rubric, applied by AI to every idea before it goes live — so the catalog is comparable, not a feed. Sort by the dimension you care about:
Evidence strength
How well the linked research backs the idea — stronger when multiple independent papers converge on the finding it relies on.
Market pull
Whether the named target companies are real buyers with budget for this.
Novelty & moat
Defensibility — a real edge vs. something trivially copyable.
Feasibility
Whether a small team could build a credible demo soon.
Wedge clarity
Whether there's a sharp, specific first use case to land.
Simplicity / focus
One sharp product with a single clear wedge — not a vague, over-scoped platform.
Top of the pipeline
Strong-tier ideas, ranked by score and research support. Each links its sources, market analysis, and a working prototype. Interested in one? Every idea page has an “Invest in this” button.
A high-potential companion diagnostic that leverages a specific genetic/metabolic bottleneck to solve the 'non-responder' problem in the massive GLP-1RA market.
Backed by 3 papers
A high-potential drug discovery play that leverages a specific structural discovery to decouple antidepressant efficacy from hallucinogenic side effects.
Backed by 4 papers
A highly focused, scientifically grounded assay service that targets a specific pharmacological gap in the high-value psychedelic-derivative drug market.
Backed by 3 papers
A highly focused, evidence-backed decision tool for government infrastructure planning with a clear value proposition and a specific entry point.
Backed by 3 papers
A highly focused B2B tool that transforms academic LCA and energy-saving models into a practical decision-support tool for automotive material selection.
Backed by 5 papers
A highly focused, evidence-backed seed program targeting a specific, high-demand crop failure with a clear genetic pathway to restoration.
Seedlabs publishes AI-generated assessments for comparison, not investment advice — always do your own diligence.